首页 > 最新文献

International Journal of Research in Pharmaceutical Sciences最新文献

英文 中文
The review on: “Creutzfeldt-Jakob disease” “克雅氏病”的研究进展
Pub Date : 2022-03-21 DOI: 10.26452/ijrps.v13i1.19
Pradnya D Jadhav, Vaibhav V Kakade, Aniket E Indrale
This review will explore the information about Creutzfeldt -Jakob disease (CJD), which is the human prion disease. CJD is a rare brain disorder and rapidly progressive. CJD belongs to the family of human prion disease, which is caused by misfolded, transmissible infections particles, or prions. Transmissible spongiform encephalopathy (TSEs), also known as prion disease. Spongiform refers to the characteristic appearance of infected brains. CJD affects about one person in every one million people per year worldwide. CJD is a fatal neurodegenerative disorder which is having a higher mortality rate. CJD usually appears in later life and has a high incubation period but become rapidly progressive once clinically symptoms begin. CJD exist in three major groups sporadic CJD (sCJD), Acquired CJD, and Genetic CJD. The sporadic form generally affects the late middle age or elderly persons (Mean age of 67 years). Most people with clinically diagnosed CJD die within a year. Other neurodegenerative illness like Alzheimer's disease involves the deposition of an aberrantly folded protein: although CJD is transmissible. There is no specific treatment for CJD except for supportive care. The arrangement of different clinicians and surveillance programs can maintain awareness of CJD to control the future incidence of its transmission.
本文就克雅氏病(Creutzfeldt -Jakob disease, CJD)这一人类朊病毒疾病的研究进展作一综述。克雅氏病是一种罕见的脑部疾病,病情发展迅速。克雅氏病属于人类朊病毒病家族,由错误折叠的传染性感染颗粒或朊病毒引起。传染性海绵状脑病(tse),也称为朊病毒病。海绵状是指受感染大脑的特征性外观。全世界每年每一百万人中就有一人患有克雅氏病。克雅氏病是一种致命的神经退行性疾病,死亡率较高。克雅氏病通常出现在晚年,潜伏期长,但一旦出现临床症状就会迅速进展。CJD主要分为散发性CJD、获得性CJD和遗传性CJD三大类。散发形式通常影响中老年或老年人(平均年龄67岁)。大多数临床诊断为CJD的人在一年内死亡。其他神经退行性疾病,如阿尔茨海默病,涉及一种异常折叠蛋白质的沉积:尽管CJD是可传播的。除了支持性护理外,没有针对CJD的特殊治疗方法。安排不同的临床医生和监测项目可以保持对克雅氏病的认识,以控制其传播的未来发生率。
{"title":"The review on: “Creutzfeldt-Jakob disease”","authors":"Pradnya D Jadhav, Vaibhav V Kakade, Aniket E Indrale","doi":"10.26452/ijrps.v13i1.19","DOIUrl":"https://doi.org/10.26452/ijrps.v13i1.19","url":null,"abstract":"This review will explore the information about Creutzfeldt -Jakob disease (CJD), which is the human prion disease. CJD is a rare brain disorder and rapidly progressive. CJD belongs to the family of human prion disease, which is caused by misfolded, transmissible infections particles, or prions. Transmissible spongiform encephalopathy (TSEs), also known as prion disease. Spongiform refers to the characteristic appearance of infected brains. CJD affects about one person in every one million people per year worldwide. CJD is a fatal neurodegenerative disorder which is having a higher mortality rate. CJD usually appears in later life and has a high incubation period but become rapidly progressive once clinically symptoms begin. CJD exist in three major groups sporadic CJD (sCJD), Acquired CJD, and Genetic CJD. The sporadic form generally affects the late middle age or elderly persons (Mean age of 67 years). Most people with clinically diagnosed CJD die within a year. Other neurodegenerative illness like Alzheimer's disease involves the deposition of an aberrantly folded protein: although CJD is transmissible. There is no specific treatment for CJD except for supportive care. The arrangement of different clinicians and surveillance programs can maintain awareness of CJD to control the future incidence of its transmission.","PeriodicalId":14285,"journal":{"name":"International Journal of Research in Pharmaceutical Sciences","volume":"16 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72941969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Effect of an Ayurvedic Intervention (Ayush-64) as a Stand-Alone Treatment in Mild to Moderate COVID-19: An Exploratory Prospective Single-Arm Clinical Trial 阿育吠陀干预(Ayush-64)作为轻中度COVID-19单独治疗的效果:一项探索性前瞻性单组临床试验
Pub Date : 2022-03-21 DOI: 10.26452/ijrps.v13i1.22
Singh N R, Amit, Babita Yadav, Arun Gupta, Rakesh Rana, Vishakha Rajesh Wetal, Neha Dubey, Sophia Jameela, Richa Singhal, Shruti Khanduri, Sharma B S, Rao BCS, Bharti, Srikanth N, Dhiman K S
An Ayurvedic polyherbal formulation (Ayush-64) was repurposed for use in mild to moderate COVID-19 cases based on the supportive evidence obtained from a pilot study on its effect on Influenza like illness (ILI) and molecular docking study which revealed that several compounds isolated from Ayush-64 demonstrated antiviral activity. The study aims at evaluating the effect of an Ayurvedic intervention (Ayush-64) in mild to moderate COVID-19 patients. A prospective single arm, pilot study in mild to moderate COVID-19 patients.  The study was conducted at Chaudhary Brahm Prakash Ayurved Charak Sansthan (CBPACS), New Delhi, India. A total of 37 COVID-19 participants confirmed through RT-PCR were included in the study. The proportion of participants with negative SARS-CoV-2 on nasal or throat swab in a 2-day consecutive real-time RT-PCR test was evaluated as the secondary outcome. In the study, 86.1% of participants demonstrated clinical recovery with 14 days of use of Ayush-64 as stand-alone treatment without any other conventional medicines, out of which 75% clinically recovered within 8 days. Further, 69.4% of participants turned negative by the 15th day, out of which 50% became COVID-19 negative on the 8th day. No AE/ ADR was observed during the study. Ayush-64 may significantly facilitate clinical improvement in terms of duration for clinical recovery and attaining negative conversion in mild to moderate COVID-19 cases.
基于一项关于其对流感样疾病(ILI)作用的初步研究和分子对接研究获得的支持性证据,一种阿育吠德多草药配方(Ayush-64)被重新用于治疗轻中度COVID-19病例,该研究显示,从Ayush-64中分离的几种化合物显示出抗病毒活性。该研究旨在评估阿育吠陀干预(Ayush-64)对轻中度COVID-19患者的影响。一项针对轻至中度COVID-19患者的前瞻性单组试点研究。这项研究是在印度新德里的Chaudhary Brahm Prakash Ayurved Charak Sansthan (CBPACS)进行的。共有37名通过RT-PCR确诊的COVID-19参与者被纳入研究。在连续2天的实时RT-PCR检测中,受试者鼻或咽拭子上SARS-CoV-2阴性的比例作为次要结局进行评估。在该研究中,86.1%的参与者在不使用任何其他常规药物的情况下,使用Ayush-64作为单独治疗14天后表现出临床恢复,其中75%的患者在8天内临床恢复。此外,69.4%的参与者在第15天变为阴性,其中50%的参与者在第8天变为阴性。研究过程中未发生不良反应。在轻至中度COVID-19病例中,Ayush-64可显著促进临床改善,缩短临床恢复时间并实现阴性转化。
{"title":"Effect of an Ayurvedic Intervention (Ayush-64) as a Stand-Alone Treatment in Mild to Moderate COVID-19: An Exploratory Prospective Single-Arm Clinical Trial","authors":"Singh N R, Amit, Babita Yadav, Arun Gupta, Rakesh Rana, Vishakha Rajesh Wetal, Neha Dubey, Sophia Jameela, Richa Singhal, Shruti Khanduri, Sharma B S, Rao BCS, Bharti, Srikanth N, Dhiman K S","doi":"10.26452/ijrps.v13i1.22","DOIUrl":"https://doi.org/10.26452/ijrps.v13i1.22","url":null,"abstract":"An Ayurvedic polyherbal formulation (Ayush-64) was repurposed for use in mild to moderate COVID-19 cases based on the supportive evidence obtained from a pilot study on its effect on Influenza like illness (ILI) and molecular docking study which revealed that several compounds isolated from Ayush-64 demonstrated antiviral activity. The study aims at evaluating the effect of an Ayurvedic intervention (Ayush-64) in mild to moderate COVID-19 patients. A prospective single arm, pilot study in mild to moderate COVID-19 patients.  The study was conducted at Chaudhary Brahm Prakash Ayurved Charak Sansthan (CBPACS), New Delhi, India. A total of 37 COVID-19 participants confirmed through RT-PCR were included in the study. The proportion of participants with negative SARS-CoV-2 on nasal or throat swab in a 2-day consecutive real-time RT-PCR test was evaluated as the secondary outcome. In the study, 86.1% of participants demonstrated clinical recovery with 14 days of use of Ayush-64 as stand-alone treatment without any other conventional medicines, out of which 75% clinically recovered within 8 days. Further, 69.4% of participants turned negative by the 15th day, out of which 50% became COVID-19 negative on the 8th day. No AE/ ADR was observed during the study. Ayush-64 may significantly facilitate clinical improvement in terms of duration for clinical recovery and attaining negative conversion in mild to moderate COVID-19 cases.","PeriodicalId":14285,"journal":{"name":"International Journal of Research in Pharmaceutical Sciences","volume":"8 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79150843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
A Review on – “Heavy Menstrual Bleeding and Abdomen Pain During Periods” “经期大出血、腹痛”综述
Pub Date : 2022-03-21 DOI: 10.26452/ijrps.v13i1.20
Harshada B Shirke, Vaibhav V Kakade, Nikhil C Katore
In medical terms, heavy bleeding is the term called menstrual period with normally or abnormality concerns. Some women do not experience blood loss enough to be defined as Menorrhagia. In medical terms, Menorrhagia is defined as a common problem that women report to their physician. On average, 10 million American women face this problem every year. It means every single woman out of five women. A 30-year-old mother of two presented to her physician with two years of increased heavy menstrual bleeding (HMB) and server dysmenorrhoea. Heavy menstrual bleeding lasts for more than 7 days. In some cases, there is heavy bleeding. If there is no treatment for this problem, the person cannot live a healthy lifestyle. Due to this problem, there are chances of causing anemia. Anemia is a disease in which a person feels tired, weak or have a problem in breathing. Due to the heavy menstrual bleeding, one can't live the normal life social, physical, emotional, well-being and cannot ask for any help from others. Heavy bleeding many causes the disease, which re due to any other disease or problems. You can’t do the normal usual activities work or any other job when having heavy menstrual bleeding as compared to the normal bleeding. When the blood flow is heavy, you might suffer from painful cramps and sometimes these cramps, which one related to menorrhagia are serious and they require medical treatment. When periods are heavy, which means the pads which are used get soaked very fastly but using a double pad may give relief and also protect from heavy bleeding. 
在医学术语中,大出血被称为月经期,与正常或异常有关。有些妇女的失血不足以被定义为月经过多。在医学术语中,月经过多被定义为女性向医生报告的常见问题。平均每年有1000万美国女性面临这个问题。意思是五个女人中的每一个。一位30岁的两个孩子的母亲向她的医生提出了两年的大量月经出血(HMB)和严重的痛经。月经大出血持续7天以上。在某些情况下,会有大量出血。如果对这个问题没有治疗,这个人就不能过健康的生活方式。由于这个问题,有可能导致贫血。贫血是一种人感到疲倦、虚弱或呼吸困难的疾病。经期大量出血,使人无法过正常的社交、身体、情感、幸福生活,也无法向他人寻求任何帮助。大量出血可能会导致这种疾病,这是由于任何其他疾病或问题。你不能做正常的日常活动,工作或任何其他工作时,有大量的月经出血与正常出血相比。当血流量很大时,你可能会感到疼痛的痉挛,有时这些痉挛与月经过多有关,很严重,需要药物治疗。当月经来潮时,这意味着使用的卫生巾很快就会被浸湿,但使用双卫生巾可能会缓解这种情况,也可以防止大量出血。
{"title":"A Review on – “Heavy Menstrual Bleeding and Abdomen Pain During Periods”","authors":"Harshada B Shirke, Vaibhav V Kakade, Nikhil C Katore","doi":"10.26452/ijrps.v13i1.20","DOIUrl":"https://doi.org/10.26452/ijrps.v13i1.20","url":null,"abstract":"In medical terms, heavy bleeding is the term called menstrual period with normally or abnormality concerns. Some women do not experience blood loss enough to be defined as Menorrhagia. In medical terms, Menorrhagia is defined as a common problem that women report to their physician. On average, 10 million American women face this problem every year. It means every single woman out of five women. A 30-year-old mother of two presented to her physician with two years of increased heavy menstrual bleeding (HMB) and server dysmenorrhoea. Heavy menstrual bleeding lasts for more than 7 days. In some cases, there is heavy bleeding. If there is no treatment for this problem, the person cannot live a healthy lifestyle. Due to this problem, there are chances of causing anemia. Anemia is a disease in which a person feels tired, weak or have a problem in breathing. Due to the heavy menstrual bleeding, one can't live the normal life social, physical, emotional, well-being and cannot ask for any help from others. Heavy bleeding many causes the disease, which re due to any other disease or problems. You can’t do the normal usual activities work or any other job when having heavy menstrual bleeding as compared to the normal bleeding. When the blood flow is heavy, you might suffer from painful cramps and sometimes these cramps, which one related to menorrhagia are serious and they require medical treatment. When periods are heavy, which means the pads which are used get soaked very fastly but using a double pad may give relief and also protect from heavy bleeding. ","PeriodicalId":14285,"journal":{"name":"International Journal of Research in Pharmaceutical Sciences","volume":"8 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84245058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The neuroprotective effects of the ethanolic extract of Syzygium polyanthum in benzene-induced rats 多花参醇提物对苯致大鼠的神经保护作用
Pub Date : 2022-03-19 DOI: 10.26452/ijrps.v13i1.13
Andini Mandira, Chrismis Novalinda Ginting, Linda Chiuman
The toxic and carcinogenic effects of benzene are caused by several factors such as the duration, mode and level of exposure, and individual susceptibility factors (age, gender, lifestyle, and pre-existing diseases). Syzygium polyanthum (Wight) Walp, known as the bay leaf, is a species of the Myrtaceae family. It is used as traditional medicine by various ethnic groups, especially in Southeast Asia, such as Malaysia and Indonesia. This study aimed to determine the neuroprotective effect of the ethanolic extract of Syzygium polyanthum using 44 rats. These experimental animals were divided into eleven groups, each consisting of 4 rats. The normal group was given only CMC (carboxymethyl cellulose), while negative 1 and 2 were given benzene 100 mg/kg BW every 6 and 3 days intraperitoneally. Furthermore, positive groups 1 and 2 were treated with vitamin c + benzene 100 mg/kgbw every 6 and 3 days, respectively. Group I-6 rats were given the extract at a dose of 400, 600, and 4800 mg/kgbw + benzene 100 mg/kgbw every 3 and 6 days during 21 days of the experiment. On day 22, the rats were injected with 1% ketamine and their blood samples were taken directly from the heart. This was followed by Interferon Gamma and COX-2. The result showed that the ethanolic extract of Syzygium polyanthum can reduce the biomarker of Interferon-gamma and COX-2 in benzene-induced rats.
苯的毒性和致癌作用是由若干因素引起的,如接触的持续时间、方式和水平,以及个人易感因素(年龄、性别、生活方式和已有疾病)。月桂叶(Syzygium polyanthum (Wight) Walp),俗称月桂叶,是月桂科的一种。它被许多民族用作传统药物,特别是在东南亚,如马来西亚和印度尼西亚。本研究旨在确定多花参乙醇提取物对44只大鼠的神经保护作用。实验动物分为11组,每组4只大鼠。正常组小鼠仅给予羧甲基纤维素(CMC),阴性1和阴性2小鼠分别于6天和3天腹腔注射苯100 mg/kg BW。阳性组1和阳性组2分别每6天和3 d给予维生素c +苯100 mg/kgbw。第1 -6组大鼠在21天的实验中,每3天和6天分别给予400、600、4800 mg/kgbw的提取物+苯100 mg/kgbw。在第22天,给大鼠注射1%的氯胺酮,并直接从心脏提取血液样本。随后是干扰素γ和COX-2。结果表明,芡实醇提物可降低苯致大鼠体内干扰素γ和COX-2的生物标志物。
{"title":"The neuroprotective effects of the ethanolic extract of Syzygium polyanthum in benzene-induced rats","authors":"Andini Mandira, Chrismis Novalinda Ginting, Linda Chiuman","doi":"10.26452/ijrps.v13i1.13","DOIUrl":"https://doi.org/10.26452/ijrps.v13i1.13","url":null,"abstract":"The toxic and carcinogenic effects of benzene are caused by several factors such as the duration, mode and level of exposure, and individual susceptibility factors (age, gender, lifestyle, and pre-existing diseases). Syzygium polyanthum (Wight) Walp, known as the bay leaf, is a species of the Myrtaceae family. It is used as traditional medicine by various ethnic groups, especially in Southeast Asia, such as Malaysia and Indonesia. This study aimed to determine the neuroprotective effect of the ethanolic extract of Syzygium polyanthum using 44 rats. These experimental animals were divided into eleven groups, each consisting of 4 rats. The normal group was given only CMC (carboxymethyl cellulose), while negative 1 and 2 were given benzene 100 mg/kg BW every 6 and 3 days intraperitoneally. Furthermore, positive groups 1 and 2 were treated with vitamin c + benzene 100 mg/kgbw every 6 and 3 days, respectively. Group I-6 rats were given the extract at a dose of 400, 600, and 4800 mg/kgbw + benzene 100 mg/kgbw every 3 and 6 days during 21 days of the experiment. On day 22, the rats were injected with 1% ketamine and their blood samples were taken directly from the heart. This was followed by Interferon Gamma and COX-2. The result showed that the ethanolic extract of Syzygium polyanthum can reduce the biomarker of Interferon-gamma and COX-2 in benzene-induced rats.","PeriodicalId":14285,"journal":{"name":"International Journal of Research in Pharmaceutical Sciences","volume":"93 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80428309","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Activity of Gaharu (Aquilaria malaccensis Lam) Leaves Extract and Fraction as Herbal Drug Against α-Glucosidase Inhibition 木香叶提取物及提取物对α-葡萄糖苷酶抑制活性的研究
Pub Date : 2022-03-19 DOI: 10.26452/ijrps.v13i1.17
Aris Suhardiman, Ketut Adnyana I., Ika Kurnia Sukamawati, Titin Rostinawati
Diabetes mellitus in 2020 in the world was 422 million people, and 1,6 million deaths are directly attributed to diabetes each year. Diabetes mellitus is a disease characterized by increased levels of glucose in the blood due to impaired function of the pancreas gland in producing the hormone insulin. One of the mechanisms of action of the antidiabetic drug class is α-glucosidase enzyme inhibitors. Compounds that play a role in the inhibitory activity of the α-glucosidase enzyme from plant extracts are flavonoids. Agarwood (Aquilaria malaccensis Lam) plants contain secondary metabolites such as alkaloids, flavonoids, saponins, quinones, tannins and steroids/triterpenoids. Gaharu leaves were extracted by maceration method using 96% ethanol solvent, then the extract obtained was fractionated using a liquid-liquid extraction method with n-hexane, ethylacetate and methanol-water as solvents. The extracts and fractions obtained were tested for inhibition of the α-glucosidase enzyme as measured by a microplate reader at a wavelength of 405 nm and acarbose as a comparison. The inhibitory activity of the α-glucosidase enzyme is expressed by the IC50  value. The inhibitory activity of α-glucosidase enzyme from extracts and fractions of n-hexane, ethylacetate and methanol-water were 90,87 µg/ml; 908,53 µg/ml; 89,78 µg/ml and 35,89 µg/ml and acarbose 19,08 µg/ml. The methanol-water fraction showed a very strong inhibitory activity against the α-glucosidase enzyme.
到2020年,全世界有4.22亿人患有糖尿病,每年有160万人直接死于糖尿病。糖尿病是一种疾病,其特征是由于胰腺分泌激素胰岛素的功能受损而导致血液中葡萄糖水平升高。降糖类药物的作用机制之一是α-葡萄糖苷酶抑制剂。从植物提取物中提取的抑制α-葡萄糖苷酶活性的化合物是类黄酮。沉香(Aquilaria malaccensis Lam)植物含有次生代谢物,如生物碱、类黄酮、皂苷、醌、单宁和类固醇/三萜。以96%乙醇为溶剂,采用浸渍法提取荆芥叶,再以正己烷、乙酸乙酯和甲醇-水为溶剂,采用液-液萃取法对提取物进行分馏。提取的提取物和馏分对α-葡萄糖苷酶的抑制作用用酶标仪测定,波长为405 nm,以阿卡波糖为对照。α-葡萄糖苷酶的抑制活性用IC50值表示。正己烷、乙酸乙酯和甲醇-水提取物和馏分对α-葡萄糖苷酶的抑制活性分别为90、87µg/ml;现年53岁的908µg / ml;89、78µg/ml、35、89µg/ml和阿卡波糖19、08µg/ml。甲醇-水组分对α-葡萄糖苷酶具有很强的抑制活性。
{"title":"Activity of Gaharu (Aquilaria malaccensis Lam) Leaves Extract and Fraction as Herbal Drug Against α-Glucosidase Inhibition","authors":"Aris Suhardiman, Ketut Adnyana I., Ika Kurnia Sukamawati, Titin Rostinawati","doi":"10.26452/ijrps.v13i1.17","DOIUrl":"https://doi.org/10.26452/ijrps.v13i1.17","url":null,"abstract":"Diabetes mellitus in 2020 in the world was 422 million people, and 1,6 million deaths are directly attributed to diabetes each year. Diabetes mellitus is a disease characterized by increased levels of glucose in the blood due to impaired function of the pancreas gland in producing the hormone insulin. One of the mechanisms of action of the antidiabetic drug class is α-glucosidase enzyme inhibitors. Compounds that play a role in the inhibitory activity of the α-glucosidase enzyme from plant extracts are flavonoids. Agarwood (Aquilaria malaccensis Lam) plants contain secondary metabolites such as alkaloids, flavonoids, saponins, quinones, tannins and steroids/triterpenoids. Gaharu leaves were extracted by maceration method using 96% ethanol solvent, then the extract obtained was fractionated using a liquid-liquid extraction method with n-hexane, ethylacetate and methanol-water as solvents. The extracts and fractions obtained were tested for inhibition of the α-glucosidase enzyme as measured by a microplate reader at a wavelength of 405 nm and acarbose as a comparison. The inhibitory activity of the α-glucosidase enzyme is expressed by the IC50  value. The inhibitory activity of α-glucosidase enzyme from extracts and fractions of n-hexane, ethylacetate and methanol-water were 90,87 µg/ml; 908,53 µg/ml; 89,78 µg/ml and 35,89 µg/ml and acarbose 19,08 µg/ml. The methanol-water fraction showed a very strong inhibitory activity against the α-glucosidase enzyme.","PeriodicalId":14285,"journal":{"name":"International Journal of Research in Pharmaceutical Sciences","volume":"40 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76975779","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Development of n-HA/CS-GM biomimetic nanocomposite for biomedical applications 生物医学应用n-HA/CS-GM仿生纳米复合材料的研制
Pub Date : 2022-03-19 DOI: 10.26452/ijrps.v13i1.15
Aswathy C, Jenson Samraj J, Gurusamy Annadurai
Nowadays, effective treatment and management of malignant osteomyelitis remain an alarming clinical challenge causing the creation of antimicrobial biomaterials for orthopedic surgeons. The has revived attention in creating antimicrobial biomaterials for orthopedics. The collaboration of nanotechnology and engineered biomaterials will probably provide perception for developing novel and hybrid composites. Because of improved control of the interaction between nanoparticles and polymers, nanohydroxyapatite (n-HA) incorporated nanocomposite would provide versatility in designing specific properties. As a result, the study describes the ethanolic extraction of Guar gum from native Cassia fistula seeds, as well as the development of (n-HA), Chitosan (CS), and Guar gum (GM) nanocomposite via the Co-precipitation method. The nanocomposites were characterized based on their physicochemical and morphological properties, such as XRD, FT-IR, and SEM. The nanocomposites were tested for antibacterial activity against Staphylococcus aureus(S.aureus) ATCC25923 and anticancer activity against MG 63 (osteosarcoma) cancer cell line MTT assay. The antibacterial result confirms that the n-HA/CS-GM hybrid nanocomposites exhibit excellent antibacterial properties against Staphylococcus aureus and average inhibition zones of the different content samples against S. aureus were 15.75 mm for n-HA/CS and 19.75 mm for n-HA/CS-GM hybrid microspheres, respectively. The cytotoxicity result showed that the average OD of cells treated with 7.8 to 1000 µg/mL concentration of n-HA/CS composite varied from 0.479 to 0.297 parallel to 88.70% to 55% cell viability, and the OD of n-HA/CS-GM composite varied from 0.447 to 0.273 corresponding 82.77% to 50.55% cell viability for 7.8µg/mL concentration up to 1000µg/mL.
如今,恶性骨髓炎的有效治疗和管理仍然是一个令人担忧的临床挑战,导致骨科医生创造抗菌生物材料。它重新引起了人们对制造用于骨科的抗菌生物材料的关注。纳米技术和工程生物材料的合作可能会为开发新型混合复合材料提供思路。纳米羟基磷灰石(n-HA)纳米复合材料可以更好地控制纳米颗粒与聚合物之间的相互作用,从而在设计特定性能时提供多功能性。因此,本研究描述了从天然决明子中乙醇提取瓜尔胶,并通过共沉淀法开发了(n-HA)、壳聚糖(CS)和瓜尔胶(GM)纳米复合材料。采用XRD、FT-IR、SEM等手段对复合材料进行了理化和形貌表征。对纳米复合材料进行了对金黄色葡萄球菌(S.aureus) ATCC25923的抑菌活性和对mg63(骨肉瘤)癌细胞的抗肿瘤活性MTT试验。结果表明,n-HA/CS- gm杂化纳米复合材料对金黄色葡萄球菌具有良好的抑菌性能,不同含量样品对金黄色葡萄球菌的平均抑制面积分别为15.75 mm和19.75 mm。细胞毒性实验结果表明,7.8 ~ 1000µg/mL n-HA/CS复合物对细胞的平均OD值为0.479 ~ 0.297,对应88.70% ~ 55%的细胞活力;7.8µg/mL ~ 1000µg/mL n-HA/CS- gm复合物对细胞的平均OD值为0.447 ~ 0.273,对应82.77% ~ 50.55%的细胞活力。
{"title":"Development of n-HA/CS-GM biomimetic nanocomposite for biomedical applications","authors":"Aswathy C, Jenson Samraj J, Gurusamy Annadurai","doi":"10.26452/ijrps.v13i1.15","DOIUrl":"https://doi.org/10.26452/ijrps.v13i1.15","url":null,"abstract":"Nowadays, effective treatment and management of malignant osteomyelitis remain an alarming clinical challenge causing the creation of antimicrobial biomaterials for orthopedic surgeons. The has revived attention in creating antimicrobial biomaterials for orthopedics. The collaboration of nanotechnology and engineered biomaterials will probably provide perception for developing novel and hybrid composites. Because of improved control of the interaction between nanoparticles and polymers, nanohydroxyapatite (n-HA) incorporated nanocomposite would provide versatility in designing specific properties. As a result, the study describes the ethanolic extraction of Guar gum from native Cassia fistula seeds, as well as the development of (n-HA), Chitosan (CS), and Guar gum (GM) nanocomposite via the Co-precipitation method. The nanocomposites were characterized based on their physicochemical and morphological properties, such as XRD, FT-IR, and SEM. The nanocomposites were tested for antibacterial activity against Staphylococcus aureus(S.aureus) ATCC25923 and anticancer activity against MG 63 (osteosarcoma) cancer cell line MTT assay. The antibacterial result confirms that the n-HA/CS-GM hybrid nanocomposites exhibit excellent antibacterial properties against Staphylococcus aureus and average inhibition zones of the different content samples against S. aureus were 15.75 mm for n-HA/CS and 19.75 mm for n-HA/CS-GM hybrid microspheres, respectively. The cytotoxicity result showed that the average OD of cells treated with 7.8 to 1000 µg/mL concentration of n-HA/CS composite varied from 0.479 to 0.297 parallel to 88.70% to 55% cell viability, and the OD of n-HA/CS-GM composite varied from 0.447 to 0.273 corresponding 82.77% to 50.55% cell viability for 7.8µg/mL concentration up to 1000µg/mL.","PeriodicalId":14285,"journal":{"name":"International Journal of Research in Pharmaceutical Sciences","volume":"48 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76489784","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Synthesis and Characterization of Chitosan with Silica (CS) Nanocomposite with Enhanced Antibacterial Activity 增强抗菌活性的壳聚糖-二氧化硅纳米复合材料的合成与表征
Pub Date : 2022-03-19 DOI: 10.26452/ijrps.v13i1.16
Bhuvaneswari P, Shanmugavadivu T, Sabeena G, Annadurai G, Sindhuja E
A mixture of nanocomposite material has been obtained by in situ formations of an inorganic network in the presence of a preformed organic polymer. Chitosan biopolymer is the most common and then silica is used in composite materials, which were used for the sol-gel reaction. The average particles size of nanocomposite powder is 63.33nm as measured by XRD. Chitosan-silica nanocomposite (CS) has a rough surface texture which appears as agglomerates of varied sizes and shapes of microfibrils and separate binding crystalline structure measured by SEM. The agar well diffusion assay is used to confirm the inhibition zone of bacteria. The nanocomposite showed antibacterial activity when tested against the pathogens gram-positive bacteria and gram-negative bacteria. Further, the synthesized nanocomposite was characterized by using X-ray powder diffraction (XRD), scanning electron microscopy with energy-dispersive X-ray spectroscopy (SEM-EDX), Particle size analysis (PSA), UV–vis absorption spectroscopy (UV) and Fourier transform infrared spectroscopy (FTIR).
在预先形成的有机聚合物存在的情况下,通过原位形成无机网络获得了纳米复合材料的混合物。壳聚糖是最常见的生物聚合物,二氧化硅是复合材料,用于溶胶-凝胶反应。XRD测定的纳米复合粉体的平均粒径为63.33nm。壳聚糖-二氧化硅纳米复合材料(CS)具有粗糙的表面纹理,表现为不同大小和形状的微纤维团块和分离的结合晶体结构。采用琼脂孔扩散法确定细菌的抑菌区。该纳米复合材料对病原菌革兰氏阳性菌和革兰氏阴性菌均表现出抗菌活性。利用x射线粉末衍射(XRD)、x射线能谱扫描电镜(SEM-EDX)、粒度分析(PSA)、紫外-可见吸收光谱(UV)和傅里叶变换红外光谱(FTIR)对合成的纳米复合材料进行了表征。
{"title":"Synthesis and Characterization of Chitosan with Silica (CS) Nanocomposite with Enhanced Antibacterial Activity","authors":"Bhuvaneswari P, Shanmugavadivu T, Sabeena G, Annadurai G, Sindhuja E","doi":"10.26452/ijrps.v13i1.16","DOIUrl":"https://doi.org/10.26452/ijrps.v13i1.16","url":null,"abstract":"A mixture of nanocomposite material has been obtained by in situ formations of an inorganic network in the presence of a preformed organic polymer. Chitosan biopolymer is the most common and then silica is used in composite materials, which were used for the sol-gel reaction. The average particles size of nanocomposite powder is 63.33nm as measured by XRD. Chitosan-silica nanocomposite (CS) has a rough surface texture which appears as agglomerates of varied sizes and shapes of microfibrils and separate binding crystalline structure measured by SEM. The agar well diffusion assay is used to confirm the inhibition zone of bacteria. The nanocomposite showed antibacterial activity when tested against the pathogens gram-positive bacteria and gram-negative bacteria. Further, the synthesized nanocomposite was characterized by using X-ray powder diffraction (XRD), scanning electron microscopy with energy-dispersive X-ray spectroscopy (SEM-EDX), Particle size analysis (PSA), UV–vis absorption spectroscopy (UV) and Fourier transform infrared spectroscopy (FTIR).","PeriodicalId":14285,"journal":{"name":"International Journal of Research in Pharmaceutical Sciences","volume":"14 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82671119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigating the flow behaviour of pharmaceutical blends using shear cell methodology 用剪切细胞方法研究药物共混物的流动行为
Pub Date : 2022-03-19 DOI: 10.26452/ijrps.v13i1.18
Hasan Aldewachi, Hiba R Tawfeeq, Thamer A. Omar
Powder flow properties are critical bulk level features for the manufacturing of solid dosage forms. Small-scale powder flow measurements are also widely accepted as a tool for predicting large-scale production failure. The aim of this study is to explore the flow properties of a two-component powder mixture and investigate the effect of mixing two powders with different properties on the flow properties parameters. To achieve this aim, 12 blends were prepared using an acoustic mixer (Labram). The flow properties were studied using rotational shear cell methodology. The results showed that the addition of Micr APAP into the excipients with good flow properties significantly increased the flow resistance of the prepared blends and consequently reduced their flow properties. The main driving factor in determining the flow properties is the particle size of the blend’s components. The results of this study suggest that it is very important to measure the flow properties of any pharmaceutical blends and not depend only on the flow properties of the original components before mixing.
粉末流动特性是制造固体剂型的关键散装级特征。小型粉末流动测量也被广泛接受为预测大规模生产故障的工具。本研究的目的是探索双组分粉末混合物的流动性能,并研究两种不同性能的粉末混合对流动性能参数的影响。为了实现这一目标,使用声学混合器(Labram)制备了12种混合物。采用旋转剪切单元法对其流动特性进行了研究。结果表明,在具有良好流动性能的赋形剂中加入Micr APAP可显著提高共混物的流动阻力,从而降低其流动性能。决定流动特性的主要驱动因素是共混物组分的粒度。本研究的结果表明,测量任何药物混合物的流动特性是非常重要的,而不是仅仅依赖于混合前原始组分的流动特性。
{"title":"Investigating the flow behaviour of pharmaceutical blends using shear cell methodology","authors":"Hasan Aldewachi, Hiba R Tawfeeq, Thamer A. Omar","doi":"10.26452/ijrps.v13i1.18","DOIUrl":"https://doi.org/10.26452/ijrps.v13i1.18","url":null,"abstract":"Powder flow properties are critical bulk level features for the manufacturing of solid dosage forms. Small-scale powder flow measurements are also widely accepted as a tool for predicting large-scale production failure. The aim of this study is to explore the flow properties of a two-component powder mixture and investigate the effect of mixing two powders with different properties on the flow properties parameters. To achieve this aim, 12 blends were prepared using an acoustic mixer (Labram). The flow properties were studied using rotational shear cell methodology. The results showed that the addition of Micr APAP into the excipients with good flow properties significantly increased the flow resistance of the prepared blends and consequently reduced their flow properties. The main driving factor in determining the flow properties is the particle size of the blend’s components. The results of this study suggest that it is very important to measure the flow properties of any pharmaceutical blends and not depend only on the flow properties of the original components before mixing.","PeriodicalId":14285,"journal":{"name":"International Journal of Research in Pharmaceutical Sciences","volume":"72 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83954694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Phytosomes - An emerging approach for effective management of Dermatological Disorder 磷脂体-一种有效管理皮肤病的新方法
Pub Date : 2022-03-18 DOI: 10.26452/ijrps.v13i1.11
Deepti Dwivedi, Alok Kumar Shukla, Satya Prakash Singh
The word ”Phyto” means plant, and also sometimes, it can be signified as cell- like. The development of phytosomes produces a little cell by itself, by which the active ingredient of the herbal extracts is protected from the intestinal secretions and instinctive bacteria destruction. The introduction of phyto- somes into herbal formulation is very recent and useful because they have advanced bioavailability, and they are better absorbed. Also, they consume this enhanced ability to cross lipid-rich bio membranes to finally reach the blood. Phytosomes can also be defined as complex chemical mixtures which are formulated by countering more than one mole synthetic or natural phos- pholipids phosphatidyl ethanolamine or phosphatidylserines with the one mole of another component. There are various plants materials which can be merged in the process of phytosomes, such as several herbal extracts includ- ing quercetin, grape seed, Rhein, neem, green tea, aloe vera, marigold and ginseng. The bioavailability of phytosomes further as linked to conventional herbal extracts because it has enhanced capability to penetrate the lipid bio membrane to finally reach the systemic blood circulation. Phytosomes has been categorized as a novel line for herbal drug delivery. Various conven- tional dosage forms such as gels and creams remained expressed using these constituents, but they appeared to be a better dermatological effect. Hence, phytosomes were formulated by binding phosphatidylcholine (acts as a trans- porter and protect the skin) and herbal extracts. They consist of a phospho- lipid molecular structure which includes two fat-soluble tails and a water- soluble head, and because of its dual solubility, it was absorbed better and was also used for the treatment of skin carcinomas, antiaging and skin disorders.
“Phyto”这个词的意思是植物,有时也可以表示为细胞状。磷脂体的发育本身产生一个小细胞,通过这个小细胞,草药提取物的有效成分免受肠道分泌物和本能细菌的破坏。植物体在草药配方中的引入是最近才出现的,因为它们具有较高的生物利用度,而且它们更容易被吸收。同时,它们消耗了这种增强的穿越富含脂质的生物膜的能力,最终到达血液。磷脂小体也可以被定义为复杂的化学混合物,它是通过将一摩尔以上的合成或天然磷脂、磷脂酰乙醇胺或磷脂酰丝氨酸与一摩尔的另一种成分对抗而形成的。磷脂体的合成过程中可以融合多种植物物质,如槲皮素、葡萄籽、莱茵、楝树、绿茶、芦荟、金盏花、人参等几种草药提取物。磷脂体的生物利用度进一步与传统草药提取物联系在一起,因为它具有增强的穿透脂质生物膜的能力,最终到达全身血液循环。磷脂体是一种新型的给药途径。各种常规剂型,如凝胶和面霜仍然使用这些成分表达,但它们似乎是一个更好的皮肤病学效果。因此,磷脂酰胆碱(作为转运和保护皮肤)和草药提取物结合形成磷脂酰胆碱体。它们由磷脂分子结构组成,包括两个脂溶性尾部和一个水溶性头部,由于其双溶解度,它被更好地吸收,也被用于治疗皮肤癌,抗衰老和皮肤疾病。
{"title":"Phytosomes - An emerging approach for effective management of Dermatological Disorder","authors":"Deepti Dwivedi, Alok Kumar Shukla, Satya Prakash Singh","doi":"10.26452/ijrps.v13i1.11","DOIUrl":"https://doi.org/10.26452/ijrps.v13i1.11","url":null,"abstract":"The word ”Phyto” means plant, and also sometimes, it can be signified as cell- like. The development of phytosomes produces a little cell by itself, by which the active ingredient of the herbal extracts is protected from the intestinal secretions and instinctive bacteria destruction. The introduction of phyto- somes into herbal formulation is very recent and useful because they have advanced bioavailability, and they are better absorbed. Also, they consume this enhanced ability to cross lipid-rich bio membranes to finally reach the blood. Phytosomes can also be defined as complex chemical mixtures which are formulated by countering more than one mole synthetic or natural phos- pholipids phosphatidyl ethanolamine or phosphatidylserines with the one mole of another component. There are various plants materials which can be merged in the process of phytosomes, such as several herbal extracts includ- ing quercetin, grape seed, Rhein, neem, green tea, aloe vera, marigold and ginseng. The bioavailability of phytosomes further as linked to conventional herbal extracts because it has enhanced capability to penetrate the lipid bio membrane to finally reach the systemic blood circulation. Phytosomes has been categorized as a novel line for herbal drug delivery. Various conven- tional dosage forms such as gels and creams remained expressed using these constituents, but they appeared to be a better dermatological effect. Hence, phytosomes were formulated by binding phosphatidylcholine (acts as a trans- porter and protect the skin) and herbal extracts. They consist of a phospho- lipid molecular structure which includes two fat-soluble tails and a water- soluble head, and because of its dual solubility, it was absorbed better and was also used for the treatment of skin carcinomas, antiaging and skin disorders.","PeriodicalId":14285,"journal":{"name":"International Journal of Research in Pharmaceutical Sciences","volume":"74 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83786926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Non-Alcoholic Steatohepatitis (NASH): An Update 非酒精性脂肪性肝炎(NASH):最新进展
Pub Date : 2022-03-15 DOI: 10.26452/ijrps.v13i1.7
Gnana Prakash
Non-alcoholic Steatohepatitis (NASH) is a globally rising, multifactorial disease which may be a result of obesity, diabetes (type-2), hypercholesteremia and gut dysbiosis. NASH is characterized by inflammation and fibrosis of liver tissues which further leads to hepatocellular carcinoma or liver failure. Patients with non-alcoholic fatty liver disease (NAFLD) show symptoms of NASH in which the fat accumulation in the liver exceeds 5-10%. Accumulation of this fat in the form of triglyceride in the hepatocytes is the key factor for the development of NASH. This may be caused due to increase in the flow of fatty acid and de novo lipogenesis. This abnormal retention of fat leads to lipotoxicity, which can cause apoptosis, necrosis, inflammation and an increase in oxidative stress. Since the pathological factors associated with NASH are unclear, the treatment to control the progression and management of the disease is cumbersome. Progress is being made in order to understand the cellular and molecular mechanisms associated with the pathogenesis of this condition. With studies reporting that NASH is the most common liver disease after hepatitis C, there is an increase in the demands for medical therapy and diagnosis of NASH. However, no treatment has been proven to be effective for long-term use. Gut dysbiosis, major pathways involved in NASH progression, experimental animal models and the current therapeutic strategies for NASH is discussed in the present review.
非酒精性脂肪性肝炎(NASH)是一种全球上升的多因素疾病,可能是肥胖、糖尿病(2型)、高胆固醇血症和肠道生态失调的结果。NASH的特点是肝组织的炎症和纤维化,进而导致肝细胞癌或肝衰竭。非酒精性脂肪性肝病(NAFLD)患者表现出肝脏脂肪堆积超过5-10%的NASH症状。这种脂肪在肝细胞中以甘油三酯的形式积累是NASH发展的关键因素。这可能是由于脂肪酸的流动增加和重新生成脂肪所致。这种脂肪的异常滞留会导致脂肪中毒,从而导致细胞凋亡、坏死、炎症和氧化应激的增加。由于与NASH相关的病理因素尚不清楚,控制疾病进展和管理的治疗是繁琐的。为了了解与这种疾病发病机制相关的细胞和分子机制,正在取得进展。随着研究报道NASH是丙型肝炎之后最常见的肝脏疾病,对NASH的药物治疗和诊断的需求也在增加。然而,没有一种治疗方法被证明是长期有效的。本文综述了肠道生态失调、NASH进展的主要途径、实验动物模型和目前NASH的治疗策略。
{"title":"Non-Alcoholic Steatohepatitis (NASH): An Update","authors":"Gnana Prakash","doi":"10.26452/ijrps.v13i1.7","DOIUrl":"https://doi.org/10.26452/ijrps.v13i1.7","url":null,"abstract":"Non-alcoholic Steatohepatitis (NASH) is a globally rising, multifactorial disease which may be a result of obesity, diabetes (type-2), hypercholesteremia and gut dysbiosis. NASH is characterized by inflammation and fibrosis of liver tissues which further leads to hepatocellular carcinoma or liver failure. Patients with non-alcoholic fatty liver disease (NAFLD) show symptoms of NASH in which the fat accumulation in the liver exceeds 5-10%. Accumulation of this fat in the form of triglyceride in the hepatocytes is the key factor for the development of NASH. This may be caused due to increase in the flow of fatty acid and de novo lipogenesis. This abnormal retention of fat leads to lipotoxicity, which can cause apoptosis, necrosis, inflammation and an increase in oxidative stress. Since the pathological factors associated with NASH are unclear, the treatment to control the progression and management of the disease is cumbersome. Progress is being made in order to understand the cellular and molecular mechanisms associated with the pathogenesis of this condition. With studies reporting that NASH is the most common liver disease after hepatitis C, there is an increase in the demands for medical therapy and diagnosis of NASH. However, no treatment has been proven to be effective for long-term use. Gut dysbiosis, major pathways involved in NASH progression, experimental animal models and the current therapeutic strategies for NASH is discussed in the present review.","PeriodicalId":14285,"journal":{"name":"International Journal of Research in Pharmaceutical Sciences","volume":"20 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82594845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of Research in Pharmaceutical Sciences
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1